Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Chris Hemsworth Launches KINSYN as Co-Founder, Bringing Personalized Wellness, Medical Care and Health Data Together in One Platform

      KINSYN

      News provided by

      KINSYN

      Nov 12, 2026, 08:32 ET

      Share this article

      Share this article


      Key Takeaways:

      • Actor and longevity advocate Chris Hemsworth has co-founded KINSYN, a personalized wellness platform that brings physician-guided care, prescription therapies, science-backed supplements, lab testing and health data together in one experience.
      • KINSYN is designed to connect medical records from participating U.S. healthcare systems with biomarker, wearable and lifestyle data, using proprietary AI to help providers develop more individualized recommendations based on a member's health needs and goals.
      • The platform is guided by a Medical and Scientific Advisory Board of physicians and researchers spanning metabolic health, immunology, genomics, women's health, longevity and precision medicine.
      •  KINSYN provides medical care and offers prescription therapies through its affiliated medical practices, owned and operated by licensed medical professionals.

      LOS ANGELES, Nov. 12, 2026 /PRNewswire/ -- KINSYN, a next-generation personalized wellness platform co-founded by actor and longevity advocate Chris Hemsworth, today launches a physician-guided approach designed to help people better understand and take a more proactive role in their health.

      Continue Reading
      Chris Hemsworth, KINSYN Co-Founder
      Chris Hemsworth, KINSYN Co-Founder

      The platform is designed to bring together medical records from participating U.S. healthcare systems with biomarker, wearable and lifestyle data to create a more complete picture of each member's health. Proprietary AI helps give providers deeper insight to inform individualized recommendations. Through one platform, members can access personalized care that may include prescription therapies, science-backed supplements and biomarker testing based on their individual health needs and medical eligibility.

      "To me, longevity is not just about living longer. It's about how you experience your life along the way. The more I've learned in this space, the more I've realized that there isn't one answer for everyone, and that understanding your own health is a critical first step," said Chris Hemsworth, co-founder of KINSYN. "KINSYN provides an opportunity to take ownership of your health and approach wellness with a better understanding of what works for you. We can't wait to support people on that journey."

      Hemsworth's passion for wellness and longevity has grown from a desire to better understand how lifestyle, health and science can influence how we feel and function throughout our lives. His perspective helped shape the vision for KINSYN, bringing together medical and scientific experts to create a platform focused on helping people become more proactive about their well-being.

      What does KINSYN mean for people looking to take a more personalized approach to their health?

      Healthcare and wellness have become increasingly fragmented, with medical records, lab results, wearable data, supplements, and treatments often existing across separate providers and platforms. Despite having access to more health information than ever before, people still struggle to translate that information into meaningful, personalized care.

      "The future of health isn't about more data, more treatments, or more disconnected solutions. It's about bringing everything together to understand the whole person and turn that understanding into meaningful action," said Matt Kawadler, CEO of KINSYN. "We built KINSYN around a simple but powerful belief: healthcare should be as unique as the individual. By combining advanced technology, medical expertise, and personalized solutions into one connected experience, we're building an entirely new approach to how people understand, manage, and optimize their health."

      Members can explore KINSYN's range of longevity-focused solutions based on their individual health needs and goals, with the option to answer a few simple questions to receive personalized recommendations. Members can connect with a licensed medical provider for an evaluation, access ongoing support from the KINSYN healthcare team throughout their health journey, and obtain prescription treatments when appropriate. KINSYN's evolving portfolio of innovative treatments and wellness solutions is designed to help members take a proactive approach to their health, performance, and longevity.

      Depending on individual health needs and goals, KINSYN's offerings include prescription therapies such as tirzepatide and semaglutide for metabolic health and weight management; longevity-focused treatments including NAD+, glutathione, sermorelin, and B12 injectables; innovative skin and hair solutions, including copper peptides and topical treatments; as well as comprehensive biomarker testing and a curated range of science-backed supplements supporting metabolic health, performance, and longevity. Members can access the KINSYN patient portal to view their treatment plans, track progress, and receive ongoing support from medical professionals.

      How is KINSYN different from existing wellness and telehealth approaches?

      Rather than focusing on a single treatment, condition or piece of health data, KINSYN takes a more complete view of each member's health. The platform is designed to connect medical records from participating U.S. healthcare systems with biomarker analysis, wearable and lifestyle data, and proprietary AI, helping provide deeper insight to providers and enable a seamless partnership that puts the patient first.

      KINSYN is led by Chief Medical Officer Dr. Jonathan Schoeff, a board-certified  surgeon and co-founder of The Longevity Lab, specializing in metabolic health, hormone optimization, and personalized longevity care.

      The platform is also guided by a Medical and Scientific Advisory Board of physicians and scientists with experience across leading academic and clinical institutions. The board helps ensure KINSYN's programs are dedicated to evidence-based medicine and individualized care.

      The Advisory Board includes:

      • Dr. Michael Snyder: Stanford geneticist and pioneer in genomics, wearable health data and early disease detection.
      • Dr. Tanya Laidlaw: Harvard Medical School professor and leading expert in immunology and systemic inflammation.
      • Dr. Nick Norwitz: Harvard-trained physician and Oxford-trained researcher specializing in metabolic health, nutrition science and GLP-1s.
      • Dr. Molly Maloof: Longevity physician specializing in women's health, hormones and personalized care.
      • Dr. Gus Vickery: Board-certified family practice physician and precision medicine expert with more than a decade of clinical experience using peptide therapies.

      "Healthcare is completely fragmented, with such an emphasis placed on treating disease, not necessarily improving human health. KINSYN is taking a completely different view of the individuals health journey, prioritizing human health outcomes and optimization, helping people make decisions that can support healthier, happier, and longer lives," said Dr. Jonathan Schoeff, KINSYN Chief Medical Officer. "I'm excited to be part of the team and working alongside Chris, Matt and the other medical advisory board members to help bring that vision to life."

      What happens next?

      With the launch of KINSYN, members can begin exploring a personalized approach to wellness that combines their health information with access to physician-guided care, testing, supplements and eligible treatments through one platform.

      KINSYN's approach is grounded in clinical oversight and patient safety. Prescription therapies are sourced through independent, 503A-compliant compounding pharmacies that are licensed, inspected and held to applicable state and federal standards. All prescriptions are subject to the independent clinical judgment of the treating clinician; no prescriptions are guaranteed through the platform.

      To learn more about KINSYN, please visit KINSYN.com.

      About KINSYN
      KINSYN is a personalized wellness platform co-founded by Chris Hemsworth that brings physician-guided care, prescription therapies, science-backed supplements, lab testing and health data together in one experience. KINSYN is designed to connect medical records from participating U.S. healthcare systems with biomarker, wearable and lifestyle data to help providers develop individualized recommendations based on each member's health needs and goals. Guided by a Medical and Scientific Advisory Board of leading physicians and researchers, KINSYN is designed to help people better understand their health and take a more proactive approach to living healthier, longer lives. To learn more, visit KINSYN.com.

      KINSYN Media Contact:
      Susie Dunlea
      Interdependence
      [email protected] 
      513-317-7024

      SOURCE KINSYN

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.